Baiyunshan Pharma Schedules First Extraordinary General Meeting of 2026 to Approve Directors’ Remuneration Measures

Bulletin Express
08/07

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has issued a proxy form for its first extraordinary general meeting (EGM) of 2026, set for 10:00 a.m. on Friday, 28 August 2026, at the company’s headquarters on No. 45 Sha Mian North Street, Liwan District, Guangzhou, Guangdong Province, China.

Two ordinary resolutions will be put to a shareholder vote:

1. Adoption of the Remuneration Management Measures for Directors and Senior Management. 2. Confirmation of the 2026 remuneration package for employee-representative director Mr. Liu Hong.

Shareholders may appoint the EGM chair or another individual as proxy and are required to submit signed proxy forms—together with any notarised power of attorney, if applicable—to the company’s H-share registrar, Computershare Hong Kong Investor Services Limited, no later than 24 hours before the meeting. Joint shareholders must ensure the proxy form is signed by the first-named holder on the share register.

Attendance in person overrides any previously submitted proxy. All times referenced follow Hong Kong time.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10